BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22158562)

  • 21. Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.
    Nagaoka K; Yanagihara K; Morinaga Y; Nakamura S; Harada T; Hasegawa H; Izumikawa K; Ishimatsu Y; Kakeya H; Nishimura M; Kohno S
    Infect Immun; 2014 Feb; 82(2):587-93. PubMed ID: 24478074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
    Fukuda Y; Furuya Y; Nozaki Y; Takahata M; Nomura N; Mitsuyama J
    Diagn Microbiol Infect Dis; 2014 Feb; 78(2):168-71. PubMed ID: 24321356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The public health policy implications of understanding metabiosis.
    McCullers JA
    Cell Host Microbe; 2014 Jul; 16(1):3-4. PubMed ID: 25011101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Sharma-Chawla N; Stegemann-Koniszewski S; Christen H; Boehme JD; Kershaw O; Schreiber J; Guzmán CA; Bruder D; Hernandez-Vargas EA
    Front Immunol; 2019; 10():1864. PubMed ID: 31474978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza.
    Chen WH; Toapanta FR; Shirey KA; Zhang L; Giannelou A; Page C; Frieman MB; Vogel SN; Cross AS
    Immunol Lett; 2012 Jan; 141(2):227-34. PubMed ID: 22037624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.
    Wren JT; Blevins LK; Pang B; King LB; Perez AC; Murrah KA; Reimche JL; Alexander-Miller MA; Swords WE
    Infect Immun; 2014 Nov; 82(11):4802-12. PubMed ID: 25156728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single Cell Bottlenecks in the Pathogenesis of Streptococcus pneumoniae.
    Kono M; Zafar MA; Zuniga M; Roche AM; Hamaguchi S; Weiser JN
    PLoS Pathog; 2016 Oct; 12(10):e1005887. PubMed ID: 27732665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey.
    Berendt RF; Long GG; Walker JS
    J Infect Dis; 1975 Dec; 132(6):689-93. PubMed ID: 811714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness.
    Lenhard A; Joma BH; Siwapornchai N; Hakansson AP; Leong JM; Bou Ghanem EN
    J Vis Exp; 2022 Sep; (187):. PubMed ID: 36279528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.
    Duvigneau S; Sharma-Chawla N; Boianelli A; Stegemann-Koniszewski S; Nguyen VK; Bruder D; Hernandez-Vargas EA
    Sci Rep; 2016 Nov; 6():37045. PubMed ID: 27872472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial sinusitis and otitis media following influenza virus infection in ferrets.
    Peltola VT; Boyd KL; McAuley JL; Rehg JE; McCullers JA
    Infect Immun; 2006 May; 74(5):2562-7. PubMed ID: 16622191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biological properties and spread of Streptococcus pneumoniae].
    Kostiukova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Dec; (12):9-16. PubMed ID: 7036611
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.
    Giebink GS; Berzins IK; Marker SC; Schiffman G
    Infect Immun; 1980 Nov; 30(2):445-50. PubMed ID: 7439990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease.
    Iovino F; Brouwer MC; van de Beek D; Molema G; Bijlsma JJ
    Cell Microbiol; 2013 Jun; 15(6):870-81. PubMed ID: 23444839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae.
    Smith AM; Adler FR; Ribeiro RM; Gutenkunst RN; McAuley JL; McCullers JA; Perelson AS
    PLoS Pathog; 2013 Mar; 9(3):e1003238. PubMed ID: 23555251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.
    Camou T; Palacio R; Di Fabio JL; Hortal M
    Vaccine; 2003 May; 21(17-18):2093-6. PubMed ID: 12706699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histology and historadiography in experimental influenza virus, pneumococcal, and mixed pneumonia].
    Randaccio M; Rapellini M; Novara O; Pasquale A
    G Mal Infett Parassit; 1970 Oct; 22(10):665-6. PubMed ID: 4397443
    [No Abstract]   [Full Text] [Related]  

  • 39. Pneumococcal vaccines WHO position paper--2012.
    Wkly Epidemiol Rec; 2012 Apr; 87(14):129-44. PubMed ID: 24340399
    [No Abstract]   [Full Text] [Related]  

  • 40. The Pneumococcus and Its Critical Role in Public Health.
    Oligbu G; Fry NK; Ladhani SN
    Methods Mol Biol; 2019; 1968():205-213. PubMed ID: 30929217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.